Rana Saifi: An Exciting Time for the Bleeding Disorders Community
Rana Saifi, Regional Manager of Middle East at World Federation of Hemophilia, shared World Federation of Hemophilia’s post on LinkedIn, adding:
“Exciting time for the bleeding disorders community with this high level advocacy led by WHO Member States and supported actively by the WFH.”
Quoting World Federation of Hemophilia’s post:
“Today, the World Federation of Hemophilia joins global health leaders at the World Health Organization 158th Executive Board meeting in Geneva EB158, where a landmark Member State-led resolution on Global Action to Advance Health Equity for People with Hemophilia and Other Bleeding Disorders is on the agenda.
This resolution is led by Armenia with co-sponsorship by Bosnia & Herzegovina, Egypt, Georgia, Iraq, Latvia, Malta, Morocco, Nepal, Paraguay, Spain, Sri Lanka and Togo.
The draft resolution text can be viewed on the WHO EB158 website.
Follow us on our social media channels today, as we will share WHO EB158 live streaming web-link, as the discussion on this resolution is planned to take place later today Treatment For All.”
More posts featuring Rana Saifi.
-
Mar 20, 2026, 17:47Julie Rayes: Commenting on a Seminal NEJM Study Solving the Mystery of VITT
-
Mar 20, 2026, 17:45William Tembo: Advancing Stroke Care by Validating Acute Ischemic Treatment
-
Mar 20, 2026, 17:37Renjith Vijayakumar Selvarani: New Nanoparticle Approach Clears Brain Plaque and Restores Memory
-
Mar 20, 2026, 17:35Bawan Ahmed: New Evidence May Shift DOAC Choice in Acute DVT Management
-
Mar 20, 2026, 17:17Angelo Cascio Rizzo: CTA-Based Plaque RADS Improves Risk Stratification in ESUS
-
Mar 20, 2026, 17:09Clinical Practice Guidelines for Platelet Transfusion in Non-Surgical and Non-Traumatic Settings – CEBaP
-
Mar 20, 2026, 17:07The Rich Heterogeneity of Platelets and Its Vital Shifts Across Disease States – RPTH
-
Mar 20, 2026, 17:05Pierre Fontana: Launching the European Interuniversity Certificate in Clinical Haemostasis
-
Mar 20, 2026, 16:49Wolfgang Miesbach: A Pivotal Step Forward for Patients with von Willebrand Disease Across All Subtypes